Literature DB >> 32652912

Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment.

SeyedAhmad SeyedAlinaghi1, Maryam Ghadimi2, Mahboubeh Hajiabdolbaghi1, Mehrnaz Rasoolinejad1, Ladan Abbasian1, Malihe Hassan Nezhad3, SeyedAli Dehghan Manshadi1, Fatemeh Ghadimi1, Zahra Ahmadinejad4.   

Abstract

BACKGROUND: COVID-19 has spread globally with remarkable speed, and currently, there is limited data available exploring any aspect of the intersection between HIV and SARSCoV- 2 co-infection.
OBJECTIVE: To estimate the prevalence of clinical symptoms associated with COVID-19 among people living with HIV (PLWH) in Tehran, Iran.
DESIGN: Cross-sectional study.
METHODS: A total of 200 PLWH were recruited through the positive club via sampling, and completed the symptom-based questionnaire for COVID-19, which was delivered by trained peers.
RESULTS: Of 200 participants, respiratory symptoms, including cough, sputum, and shortness of breath, were the most prevalent among participants, but only one person developed symptoms collectively suggested COVID-19 and sought treatments.
CONCLUSION: It appears that existing infection with HIV or receiving antiretroviral treatment (ART) might reduce the susceptibility to the infection with SARS-CoV-2 or decrease the severity of the infection acquired. Further research is needed to understand causal mechanisms. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COVID-19; HIV; SARS-CoV-2; antiretroviral treatment (ART); coronavirus; pneumonia

Mesh:

Substances:

Year:  2020        PMID: 32652912     DOI: 10.2174/1570162X18666200712175535

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  5 in total

Review 1.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Omid Dadras; Zahra Pashaei; Amirali Karimi; Mehrzad MohsseniPour; Mahdi Soleymanzadeh; Alireza Barzegary; Amir Masoud Afsahi; Farzin Vahedi; Ahmadreza Shamsabadi; Farzane Behnezhad; Solmaz Saeidi; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-06-08       Impact factor: 2.175

Review 2.  Genetic susceptibility of COVID-19: a systematic review of current evidence.

Authors:  SeyedAhmad SeyedAlinaghi; Mohammad Mehrtak; Mehrzad MohsseniPour; Pegah Mirzapour; Alireza Barzegary; Pedram Habibi; Banafsheh Moradmand-Badie; Amir Masoud Afsahi; Amirali Karimi; Mohammad Heydari; Esmaeil Mehraeen; Omid Dadras; Jean-Marc Sabatier; Fabricio Voltarelli
Journal:  Eur J Med Res       Date:  2021-05-20       Impact factor: 2.175

3.  Risk factors of developing critical conditions in Iranian patients with COVID-19.

Authors:  Alireza Arman; Maryam Tajik; Maryam Nazemipour; Zahra Ahmadinejad; Sahar Keyvanloo Shahrestanaki; Ebrahim Hazrati; Nasrin Mansournia; Mohammad Ali Mansournia
Journal:  Glob Epidemiol       Date:  2020-12-08

4.  Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence.

Authors:  SeyedAhmad SeyedAlinaghi; Shahram Oliaei; Shaghayegh Kianzad; Amir Masoud Afsahi; Mehrzad MohsseniPour; Alireza Barzegary; Pegah Mirzapour; Farzane Behnezhad; Tayebeh Noori; Esmaeil Mehraeen; Omid Dadras; Fabricio Voltarelli; Jean-Marc Sabatier
Journal:  World J Virol       Date:  2020-12-15

Review 5.  Predictors of mortality in patients with COVID-19-a systematic review.

Authors:  Esmaeil Mehraeen; Amirali Karimi; Alireza Barzegary; Farzin Vahedi; Amir Masoud Afsahi; Omid Dadras; Banafsheh Moradmand-Badie; Seyed Ahmad Seyed Alinaghi; Shayesteh Jahanfar
Journal:  Eur J Integr Med       Date:  2020-10-17       Impact factor: 1.314

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.